VistaGen Therapeutics Inc

NASDAQ:VTGN   3:59:53 PM EDT
2.68
-0.10 (-3.60%)
Earnings Announcements

Vistagen Therapeutics Reports Fiscal Year 2021 Financial Results And Provides Corporate Update

Published: 06/29/2021 20:25 GMT
VistaGen Therapeutics Inc (VTGN) - Vistagen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update.
Revenue is expected to be $0.39 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0.39 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.